EXACT Sciences Co. (NASDAQ:EXAS) insider Kevin T. Conroy sold 11,227 shares of the firm’s stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $87.21, for a total transaction of $979,106.67. Following the transaction, the insider now directly owns 949,753 shares in the company, valued at $82,827,959.13. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Shares of EXAS stock opened at $96.15 on Friday. The stock has a market capitalization of $11.78 billion, a price-to-earnings ratio of -70.70 and a beta of 1.85. The company has a debt-to-equity ratio of 1.02, a quick ratio of 8.70 and a current ratio of 8.99. EXACT Sciences Co. has a 52 week low of $37.36 and a 52 week high of $97.27.
EXACT Sciences (NASDAQ:EXAS) last announced its quarterly earnings data on Thursday, February 21st. The medical research company reported ($0.44) EPS for the quarter, topping the consensus estimate of ($0.49) by $0.05. The business had revenue of $142.98 million for the quarter, compared to analyst estimates of $143.00 million. EXACT Sciences had a negative net margin of 38.54% and a negative return on equity of 23.58%. The company’s revenue for the quarter was up 63.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.18) earnings per share. Research analysts predict that EXACT Sciences Co. will post -1.98 earnings per share for the current year.
Institutional investors and hedge funds have recently bought and sold shares of the company. Karp Capital Management Corp purchased a new position in shares of EXACT Sciences in the fourth quarter worth about $38,000. CWM LLC increased its stake in shares of EXACT Sciences by 777.1% in the fourth quarter. CWM LLC now owns 614 shares of the medical research company’s stock worth $39,000 after purchasing an additional 544 shares in the last quarter. Hanson McClain Inc. increased its stake in shares of EXACT Sciences by 377.5% in the fourth quarter. Hanson McClain Inc. now owns 955 shares of the medical research company’s stock worth $60,000 after purchasing an additional 755 shares in the last quarter. Tortoise Investment Management LLC purchased a new position in shares of EXACT Sciences in the fourth quarter worth about $62,000. Finally, Phocas Financial Corp. purchased a new position in shares of EXACT Sciences in the fourth quarter worth about $95,000. Hedge funds and other institutional investors own 91.08% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Insider Selling: EXACT Sciences Co. (EXAS) Insider Sells 11,227 Shares of Stock” was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another website, it was copied illegally and republished in violation of international trademark and copyright laws. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/4222669/insider-selling-exact-sciences-co-exas-insider-sells-11227-shares-of-stock.html.
About EXACT Sciences
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer.
Featured Story: What is Call Option Volume?
Receive News & Ratings for EXACT Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EXACT Sciences and related companies with MarketBeat.com's FREE daily email newsletter.